BIBF 1202

CAS No. 894783-71-2

BIBF 1202( —— )

Catalog No. M29632 CAS No. 894783-71-2

BIBF 1202 is a VEGFR2 kinase inhibitor (IC50 = 62 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 61 In Stock
25MG 179 In Stock
50MG 259 In Stock
100MG 379 In Stock
200MG 537 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BIBF 1202
  • Note
    Research use only, not for human use.
  • Brief Description
    BIBF 1202 is a VEGFR2 kinase inhibitor (IC50 = 62 nM).
  • Description
    BIBF 1202 is a VEGFR2 kinase inhibitor (IC50 = 62 nM).(In Vitro):BIBF 1202 is produced in the main metabolic pathway of BIBF 1120 by the cleavage of methyl esters. Then, the free carboxyl group of BIBF 1202 is glucuronidated to 1-O-acyl glucuronide .
  • In Vitro
    The major metabolic pathway for BIBF 1120 is methyl ester cleavage to BIBF 1202. Subsequently, the free carboxyl group of BIBF 1202 is glucuronidated to 1-O-acylglucuronide.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    VEGFR
  • Recptor
    VEGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    894783-71-2
  • Formula Weight
    525.609
  • Molecular Formula
    C30H31N5O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 45 mg/mL (85.62 mM)
  • SMILES
    CN(C(=O)CN1CCN(C)CC1)c1ccc(N\C(=C2/C(=O)Nc3cc(ccc23)C(O)=O)c2ccccc2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • GW297361

    GW297361 is a potent inhibitor of the cell cycle protein-dependent kinase Cdk1 and also inhibits the Pho85 signaling pathway.The IC50s of GW297361 on yeast Cdk1 and Pho85 were 20 nM and 400 nM, respectively.

  • Pamufetinib mesylate

    Pamufetinib mesylate (TAS-115 mesylate) is a potent vascular endothelial growth factor receptor (VEGFR) antagonist and hepatocyte growth factor receptor (c-Met) inhibitor used in the study of cancer and respiratory diseases.

  • N-Desethyl Sunitinib

    N-Desethyl Sunitinib is a sunitinib metabolite.